Director Shareholding

Deltex Medical Group PLC
31 October 2003



          Deltex Medical Group plc ('Deltex Medical' or the 'Company')

                             Director Shareholdings



Deltex Medical announced on 28 October 2003, that it has placed 5,609,269 new
ordinary shares at 15p per share with various institutional and other investors
and certain of the Directors, raising approximately £840,000 before expenses.



The following Directors have participated as investors in the placing and their
interests in the Company's total enlarged issued ordinary share capital
following the placing are as follows:


                                                                       Following the placing
Name of Director               Number of placing shares         Holding of shares % of issued share capital
                                                acquired

Nigel Keen                                      133,333              3,585,577(1)                      5.81
Ewan Phillips                                   100,000                   465,714                      0.75
George Flouty                                    30,000                   164,285                      0.27
Peter Smedvig                                   280,000                944,478(2)                      1.53
Edwin Snape                                           -                 2,879,925                      4.67
Andy Hill                                             -                    42,857                      0.07
Daniel Bretonneau                                     -                   142,857                      0.23



(1)         includes 589,700 shares held as trustee and executor of Pauline
            Thomas Charity Will Trust



(2)         includes shares held as director of Peder Smedvig Capital AS



The £81,500 invested by the Directors is in addition to the total amount of
£371,780 subscribed by the Directors as part of the £1.32 million placing before
expenses announced on 7 May 2003.



Following the placing, the aggregate interest of all the Directors' interests in
the shares of the Company totals 8,225,693 ordinary shares representing 13.33%
of the issued share capital.





31 October 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange